SEC Form D filing

Cancer Focus Fund II, LP

Biotech · Growth · Regulation D 506(c) · LA · Filed May 22, 2026

Offering amount: $250.0M
Exemption: Reg D 506(c)
Issuer state: LA
Filing date: May 22, 2026
Signature date: May 21, 2026
CIK: 0002069938

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: May 2026 Stage and month: Growth

Summary

Auto-generated

Cancer Focus Fund II is a $250M biotech-focused fund; large fund size indicates growth-stage capital deployment.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.